These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 9738464

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.
    Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG, Lisanti MP.
    EMBO J; 1998 Nov 16; 17(22):6633-48. PubMed ID: 9822607
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway.
    Minshall RD, Tiruppathi C, Vogel SM, Niles WD, Gilchrist A, Hamm HE, Malik AB.
    J Cell Biol; 2000 Sep 04; 150(5):1057-70. PubMed ID: 10973995
    [Abstract] [Full Text] [Related]

  • 32. Affinity-purification and characterization of caveolins from the brain: differential expression of caveolin-1, -2, and -3 in brain endothelial and astroglial cell types.
    Ikezu T, Ueda H, Trapp BD, Nishiyama K, Sha JF, Volonte D, Galbiati F, Byrd AL, Bassell G, Serizawa H, Lane WS, Lisanti MP, Okamoto T.
    Brain Res; 1998 Sep 07; 804(2):177-92. PubMed ID: 9841091
    [Abstract] [Full Text] [Related]

  • 33. Identification of caveolae and caveolin in C6 glioma cells.
    Silva WI, Maldonado HM, Lisanti MP, Devellis J, Chompré G, Mayol N, Ortiz M, Velázquez G, Maldonado A, Montalvo J.
    Int J Dev Neurosci; 1999 Nov 07; 17(7):705-14. PubMed ID: 10568687
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Phosphofructokinase muscle-specific isoform requires caveolin-3 expression for plasma membrane recruitment and caveolar targeting: implications for the pathogenesis of caveolin-related muscle diseases.
    Sotgia F, Bonuccelli G, Minetti C, Woodman SE, Capozza F, Kemp RG, Scherer PE, Lisanti MP.
    Am J Pathol; 2003 Dec 07; 163(6):2619-34. PubMed ID: 14633633
    [Abstract] [Full Text] [Related]

  • 38. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities.
    Razani B, Combs TP, Wang XB, Frank PG, Park DS, Russell RG, Li M, Tang B, Jelicks LA, Scherer PE, Lisanti MP.
    J Biol Chem; 2002 Mar 08; 277(10):8635-47. PubMed ID: 11739396
    [Abstract] [Full Text] [Related]

  • 39. Regional distribution and molecular interaction of caveolins in bladder smooth muscle.
    Sullivan MP, Cristofaro V, Radisavljevic ZM, Yalla SV.
    BJU Int; 2012 Dec 08; 110(11 Pt C):E1163-72. PubMed ID: 22897417
    [Abstract] [Full Text] [Related]

  • 40. Membrane structure of caveolae and isolated caveolin-rich vesicles.
    Westermann M, Leutbecher H, Meyer HW.
    Histochem Cell Biol; 1999 Jan 08; 111(1):71-81. PubMed ID: 9930886
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.